Blog

Refining the First Strike Against EGFR-Mutated Advanced NSCLC – PeerView Institute for Medical Education

PVI/LinkedIn

Nov 18, 2024, 16:59

Refining the First Strike Against EGFR-Mutated Advanced NSCLC – PeerView Institute for Medical Education

PVI (PeerView Institute for Medical Education) shared a post on LinkedIn:

“Join the lung cancer experts Drs. Stephen Liu and Zosia Piotrowska on November 22 at 9:30 AM PST during MaTOS2024 for an EGFR-mutated advanced NSCLC MedEd event.

Learners will gain case-based guidance on interpreting and applying the latest innovations effectively in practice, ensuring they are well-prepared for the frontline management of EGFR-mutated NSCLC.

This activity is supported by an independent educational grant from AstraZeneca.”

Read further.

For more posts like this, visit oncodaily.com.

AstraZeneca cancer EGFR-mutated non-small-cell lung cancer EGFR-mutated NSCLC Lung cancer MaTOS2024 MedEd OncoDaily Oncology Stephen Liu Zosia Piotrowska

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage